Cellbxhealth PLC (ANPCF) Financials
ANPCF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 24.8 million | 8.8 million |
| March 31, 2025 | 23.4 million | 8.3 million |
| Dec. 31, 2024 | 32.0 million | 8.8 million |
| Sept. 30, 2024 | 34.1 million | 9.4 million |
ANPCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | -3.2 million | 284204 |
| March 31, 2025 | -3.0 million | 267836 |
| Dec. 31, 2024 | -4.4 million | -496997 |
| Sept. 30, 2024 | -4.6 million | -529670 |
ANPCF Net Income
No data available :(
ANPCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 7.2 million | - | 5.0 million |
| March 31, 2025 | 6.8 million | - | 4.7 million |
| Dec. 31, 2024 | 13.1 million | - | 5.3 million |
| Sept. 30, 2024 | 13.9 million | - | 5.6 million |
ANPCF Shares Outstanding
ANPCF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | 59724 | - | 7.0 million | - |
| March 31, 2025 | 56284 | - | 6.6 million | - |
| Dec. 31, 2024 | 176961 | 3.8 million | 5.0 million | 140564 |
| Sept. 30, 2024 | 188594 | 4.1 million | 5.3 million | 149805 |
ANPCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | 546440 | 226539 |
| March 31, 2025 | 514970 | 213492 |
| Dec. 31, 2024 | 1.1 million | 414164 |
| Sept. 30, 2024 | 1.2 million | 441391 |
ANPCF
Price: $0.02
52 week price:
Earnings Per Share: -0.06 USD
P/E Ratio: -0.23
Exchange: OQB
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 6.5 million